Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants

The requested reference [215bb7bb16a77aa7ca23ac510a883967765057de] no longer exists in our database. It has been replaced by the current reference: [f571f57e1967080c8a1870d8405d5f940113c580]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to evaluate the impact of an early treatment with Natalizumab on the management of the progressive nature of Relapsing Remitting Multiple Sclerosis (RRMS).
Epistemonikos ID: 94829459c2ed2cca61156f9ba332ca6d11ae3b02
First added on: May 08, 2024